Cargando…
Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Autores principales: | Zhang, Wenda, Yu, Wenying, Cai, Guiping, Zhu, Jiawen, Zhang, Chao, Li, Shanshan, Guo, Jianpeng, Yin, Guoping, Chen, Chen, Kong, Lingyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139949/ https://www.ncbi.nlm.nih.gov/pubmed/34021130 http://dx.doi.org/10.1038/s41419-021-03809-2 |
Ejemplares similares
-
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
por: Zhang, Wenda, et al.
Publicado: (2018) -
Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy
por: Zhang, Wenda, et al.
Publicado: (2017) -
Retracted: Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Retracted: Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
por: Xu, Xuefen, et al.
Publicado: (2022)